Regulating the Psychedelic Renaissance: FDA’s Critical Role in the Push for Scheduling Reform to Expand Research into Psychedelic Medicines

Authors

Saumya Sinha, American University Washington College of Law

Journal

American University Administrative Law Review

Volume

76

Issue

3

Abstract

Though Indigenous communities have used psychedelics in a medicinal capacity for centuries, their use in the United States has remained largely illegal since the 1970s as a result of the War on Drugs. In recent years, however, the broader sociocultural and governmental attitudes toward psychedelics have started to shift, leading to a greater push for legislative and regulatory reform—a phenomenon described as the psychedelic renaissance.

Repository Citation

Saumya Sinha, Regulating the Psychedelic Renaissance: FDA’s Critical Role in the Push for Scheduling Reform to Expand Research into Psychedelic Medicines, 76 (2024).
Available at: https://digitalcommons.wcl.american.edu/stusch_lawrev/63